30Mil CAD$ Investment in European Centre of Cancer Immunotherapy – Benzinga
|
30Mil CAD$ Investment in European Centre of Cancer Immunotherapy
Benzinga "The decision to invest in the European Centre for Cancer Immunotherapy has become obvious to me at the moment I became acquainted with the results of ongoing clinical trials and the development plan for the centre prepared by HIO. It envisages the … |
